- Novo Nordisk hit hard as U.S. rebuffs insulin drug Mette Fraende - Reuters - 1 hr 44 mins ago
COPENHAGEN (Reuters) - U.S. regulators refused to approve Novo Nordisk's new long-acting insulin Tresiba until it conducts extra tests for potential heart risks, dealing … More »Novo Nordisk hit hard as U.S. rebuffs insulin drug
COPENHAGEN (Reuters) - U.S. regulators refused to approve Novo Nordisk's new long-acting insulin Tresiba until it conducts extra tests for potential heart risks, dealing a major blow to a key product for the Danish drugmaker. Shares in Novo, the world's leading insulin maker and the most valuable company in the Nordic region, …
- What heals traumatized kids? Answers are lacking LINDSEY TANNER - AP - 9 hrs ago
CHICAGO (AP) — Shootings and other traumatic events involving children are not rare events, but there's a startling lack of scientific evidence on the best ways to help … More »What heals traumatized kids? Answers are lacking
- FDA rebuff deals big blow to Novo Nordisk's U.S. hopes Mette Fraende - Reuters - 16 hrs ago
COPENHAGEN (Reuters) - U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional … More »FDA rebuff deals big blow to Novo Nordisk's U.S. hopes
COPENHAGEN (Reuters) - U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks. Novo, the world's biggest insulin maker, said the U.S. Food and Drug Administration (FDA) had requested …
- U.S. pharmaceutical exports to Iran cut in half in 2012 Arshad Mohammed - Reuters - Fri, Feb 8, 2013
WASHINGTON (Reuters) - Exports of U.S. pharmaceuticals to Iran were cut in half last year, according to data released on Friday, while overall U.S. exports to the Islamic … More »U.S. pharmaceutical exports to Iran cut in half in 2012
WASHINGTON (Reuters) - Exports of U.S. pharmaceuticals to Iran were cut in half last year, according to data released on Friday, while overall U.S. exports to the Islamic republic rose about nine percent because of grain sales. The official U.S. government statistics appear to support the claims of sanctions lawyers and …
- FDA approves Celgene drug for multiple myeloma Toni Clarke - Reuters - Fri, Feb 8, 2013
(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with multiple myeloma whose disease has worsened after being treated with other cancer … More »FDA approves Celgene drug for multiple myeloma
(Reuters) - U.S. regulators have approved a new drug from Celgene Corp for patients with multiple myeloma whose disease has worsened after being treated with other cancer drugs. The U.S. Food and Drug Administration said on Friday it approved the drug, Pomalyst, also known as pomalidomide, for the most difficult-to-treat …
- Psychiatric drugs tied to falls in the elderly Genevra Pittman - Reuters - Fri, Feb 8, 2013
NEW YORK (Reuters Health) - Seniors taking psychiatric drugs may be at extra high risk for falling, new Dutch research suggests. Of about 400 elderly people in the study, … More »Psychiatric drugs tied to falls in the elderly
NEW YORK (Reuters Health) - Seniors taking psychiatric drugs may be at extra high risk for falling, new Dutch research suggests. Of about 400 elderly people in the study, those who took medications including antidepressants and antipsychotics were twice as likely to report having fallen three or more times in the previous …
- Oncolytics lung cancer drug shrinks tumors in 95 percent patients Reuters - Fri, Feb 8, 2013
(Reuters) - Oncolytics Biotech Inc said a mid-stage trial of its experimental lung cancer drug showed that 95 percent of the patients experienced a reduction in the size … More »Oncolytics lung cancer drug shrinks tumors in 95 percent patients
(Reuters) - Oncolytics Biotech Inc said a mid-stage trial of its experimental lung cancer drug showed that 95 percent of the patients experienced a reduction in the size of their tumors, sending its stock up as much as 38 percent. Shares of the company, with a market value of about C$279 million ($273 million) as of Thursday …
- FDA outlines path to test Alzheimer's drugs earlier Julie Steenhuysen - Reuters - Fri, Feb 8, 2013
CHICAGO (Reuters) - Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer's treatments in people at an earlier stage, when scientists think … More »FDA outlines path to test Alzheimer's drugs earlier
CHICAGO (Reuters) - Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer's treatments in people at an earlier stage, when scientists think they may have the best shot at working. The draft guidance document, issued on Thursday by the U.S. Food and Drug Administration, reflects changes in scientists' …
- Insight: GSK vaccine ingredient scrutinized for narcolepsy clues Kate Kelland, Health and Science Correspondent - Reuters - Fri, Feb 8, 2013
LONDON (Reuters) - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of … More »Insight: GSK vaccine ingredient scrutinized for narcolepsy clues
LONDON (Reuters) - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed …
- Amgen biosimilar push takes aim at blockbusters Bill Berkrot - Reuters - Thu, Feb 7, 2013
NEW YORK (Reuters) - Amgen Inc said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has … More »Amgen biosimilar push takes aim at blockbusters
NEW YORK (Reuters) - Amgen Inc said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's biggest sellers, including the main rivals for its own blockbuster rheumatoid arthritis drug Enbrel. The company on Thursday …
- Appeals court upholds patent on Merck's Vytorin Reuters - Thu, Feb 7, 2013
WASHINGTON (Reuters) - The patent on Merck & Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled … More »Appeals court upholds patent on Merck's Vytorin
WASHINGTON (Reuters) - The patent on Merck & Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled on Thursday. Vytorin combines Zocor, a member of the statin family developed by Merck, with a newer Merck cholesterol treatment called Zetia. Sales of Vytorin …
- Slow and steady can win the diet drug race Esha Dey and Zeba Siddiqui - Reuters - Thu, Feb 7, 2013
(Reuters) - Vivus Inc, vying to create the world's first billion-dollar weight-loss pill, is taking a cautious approach to marketing in an attempt to overcome the skepticism, … More »Slow and steady can win the diet drug race
(Reuters) - Vivus Inc, vying to create the world's first billion-dollar weight-loss pill, is taking a cautious approach to marketing in an attempt to overcome the skepticism, safety concerns and lawsuits that have dogged the diet drug industry. The company has lost nearly half of its market value since lackluster sales …
- Why Are Some Prescription Drugs So Hard to Get? Takepart.com - Thu, Feb 7, 2013
If you have some types of cancer and your treatment includes chemotherapy, there’s a good chance you’ll be prescribed the drug Doxil. If your doctor can get her hands … More »Why Are Some Prescription Drugs So Hard to Get?
If you have some types of cancer and your treatment includes chemotherapy, there’s a good chance you’ll be prescribed the drug Doxil. If your doctor can get her hands on any, that is. Doxil is one of many crucial drugs that’s in seriously short supply.
- Unhealthy Glow: Fluorescent Tadpoles Expose Chemical Contamination Erica Gies - Scientific American - Thu, Feb 7, 2013
Unhealthy Glow: Fluorescent Tadpoles Expose Chemical Contamination More »Unhealthy Glow: Fluorescent Tadpoles Expose Chemical Contamination
Unhealthy Glow: Fluorescent Tadpoles Expose Chemical Contamination
- Brain Buzz May Ease Depression ANN T. HAU, M.D., ABC News Medical Unit - ABC News - Wed, Feb 6, 2013
Drug-Free Technique Might Help Some Patients Who Struggle With Depression More »Brain Buzz May Ease Depression
- Biogen's purchase of MS drug ends rocky partnership with Elan Toni Clarke - Reuters - Wed, Feb 6, 2013
BOSTON (Reuters) - Biogen Idec Inc's agreement to buy Elan Corp Plc's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised … More »Biogen's purchase of MS drug ends rocky partnership with Elan
BOSTON (Reuters) - Biogen Idec Inc's agreement to buy Elan Corp Plc's interest in the multiple sclerosis drug Tysabri gives Biogen full control of a product that is poised for further growth and ends a long partnership that has often been contentious. Analysts have speculated for several years that Biogen could acquire …
- FDA warns of new fake batch of cancer drug Avastin AP - Wed, Feb 6, 2013
WASHINGTON (AP) — The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the … More »FDA warns of new fake batch of cancer drug Avastin
WASHINGTON (AP) — The Food and Drug Administration is warning U.S. doctors about another counterfeit version of the cancer drug Avastin, the third case involving the best-selling Roche drug in the past year.
- Alzheimer's to triple by 2050 as baby boomers age Julie Steenhuysen - Reuters - Wed, Feb 6, 2013
CHICAGO (Reuters) - The number of U.S. residents aged 65 and older living with Alzheimer's disease is expected to nearly triple to 13.8 million by 2050 as aging baby … More »Alzheimer's to triple by 2050 as baby boomers age
CHICAGO (Reuters) - The number of U.S. residents aged 65 and older living with Alzheimer's disease is expected to nearly triple to 13.8 million by 2050 as aging baby boomers swell the ranks of those living with the brain-wasting disease, U.S. researchers said on Wednesday. The new estimates, published in the journal Neurology, …
- Man Lost 100 lbs., Gets New Heart GILLIAN MOHNEY - ABC News - Wed, Feb 6, 2013
Suitulaga Hunkin Lost Weight for a Heart Transplant More »Man Lost 100 lbs., Gets New Heart
- A Minute With: Soderbergh about his new film "Side Effects" Zorianna Kit - Reuters - Wed, Feb 6, 2013
LOS ANGELES (Reuters) - Oscar-winning filmmaker Steven Soderbergh delves into the world of prescription drugs in his new film "Side Effects," a psychological thriller … More »A Minute With: Soderbergh about his new film "Side Effects"
LOS ANGELES (Reuters) - Oscar-winning filmmaker Steven Soderbergh delves into the world of prescription drugs in his new film "Side Effects," a psychological thriller that opens on Friday. Rooney Mara and Channing Tatum play a couple whose lives unravel when she begins taking a new anti-anxiety medication prescribed by …
- Europe faces cost cuts as GSK promises return to growth Ben Hirschler - Reuters - Wed, Feb 6, 2013
LONDON (Reuters) - GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year, after failing to … More »Europe faces cost cuts as GSK promises return to growth
LONDON (Reuters) - GlaxoSmithKline plans to cut costs in its struggling European drugs division and promised investors a return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012. Britain's biggest drugmaker said a new program to restructure European operations, drug manufacturing …
- Accused killer of decorated U.S. sniper "traded soul for truck" Marice Richter and Jim Forsyth - Reuters - Tue, Feb 5, 2013
DALLAS (Reuters) - The suspect accused of shooting dead former Navy SEAL sniper Chris Kyle and another man stole a vehicle from the scene and told his sister "I traded … More »Accused killer of decorated U.S. sniper "traded soul for truck"
DALLAS (Reuters) - The suspect accused of shooting dead former Navy SEAL sniper Chris Kyle and another man stole a vehicle from the scene and told his sister "I traded my soul for a new truck," investigators said on Tuesday. Eddie Ray Routh is being held on one count of capital murder and two counts of murder in the slayings …
- Steroid shots for tennis elbow may hurt, not help Genevra Pittman - Reuters - Tue, Feb 5, 2013
NEW YORK (Reuters Health) - Getting a cortisone injection won't cure tennis elbow any better than a drug-free saline shot, according to a new study - and it might actually … More »Steroid shots for tennis elbow may hurt, not help
NEW YORK (Reuters Health) - Getting a cortisone injection won't cure tennis elbow any better than a drug-free saline shot, according to a new study - and it might actually slow recovery. Researchers found that a few weeks after receiving the steroid shots, people reported less pain and disability than those who'd been given …
- Senate to mull ban on "pay for delay" pharmaceutical deals Reuters - Tue, Feb 5, 2013
WASHINGTON (Reuters) - Key Democratic and Republican senators reintroduced legislation on Tuesday that would make it illegal for brand-name pharmaceutical companies to … More »Senate to mull ban on "pay for delay" pharmaceutical deals
WASHINGTON (Reuters) - Key Democratic and Republican senators reintroduced legislation on Tuesday that would make it illegal for brand-name pharmaceutical companies to pay generic drug makers to keep their cheaper medicines off the market. Such deals, in which big drug companies resolve patent litigation with potentially …
- Step into the Twilight Zone: Day 4 on Mars Time, aka Easy Peasy Lemon Squeezy Katie Worth - Scientific American - Tue, Feb 5, 2013
Step into the Twilight Zone: Day 4 on Mars Time, aka Easy Peasy Lemon Squeezy More »Step into the Twilight Zone: Day 4 on Mars Time, aka Easy Peasy Lemon Squeezy
Medications/Drugs News Headlines
Today on Yahoo!
1 - 8 of 48
More Health Videos
1 - 4 of 20
Follow Yahoo! News
Follow @ Yahoo! News on Twitter
The official account of Yahoo! News. 100% feed-free tweets by news fans for news fans! More »
twitter.com